Dr Reddys Laboratories (RDY) Other Non-Current Liabilities (2012 - 2026)

Dr Reddys Laboratories' Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $37.7 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 1.26% year-over-year to $37.7 million; the TTM figure through Mar 2026 stood at $37.7 million (down 1.26% YoY), while the FY2026 annual figure was $37.0 million, down 5.13% from the prior year.
• Other Non-Current Liabilities was $37.7 million for Q1 2026 at Dr Reddys Laboratories, up from $27.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $384.7 million in Q2 2023 to a low of $27.0 million in Q3 2025.
• Historically, Other Non-Current Liabilities has averaged $108.3 million across 5 years, with a median of $37.9 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities plunged 89.02% in 2022, then surged 955.07% in 2023.
• A 5-year view of Other Non-Current Liabilities shows it stood at $35.4 million in 2022, then soared by 955.07% to $373.8 million in 2023, then plunged by 80.76% to $71.9 million in 2024, then slumped by 62.39% to $27.0 million in 2025, then soared by 39.26% to $37.7 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $37.7 million (Q1 2026), $27.0 million (Q3 2025), and $38.1 million (Q1 2025), per Business Quant data.